Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy
Victoria Marco-Benedi et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Characteristics of patients prescribed Evolocumab in Europe. Does clinical use match clinical guidelines?
K. Ray et al.
EUROPEAN HEART JOURNAL (2018)
Statins and risk of cataracts: A systematic review and meta-analysis of observational studies
Carlos Alves et al.
CARDIOVASCULAR THERAPEUTICS (2018)
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
Francois Mach et al.
EUROPEAN HEART JOURNAL (2018)
Cataract in the Adult Eye Preferred Practice Pattern®
Randall J. Olson et al.
OPHTHALMOLOGY (2017)
Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis
Shandong Yu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Seth R. Flaxman et al.
LANCET GLOBAL HEALTH (2017)
Treating inflammation after lens surgery
Thomas Kohnen
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2015)
Share Paper
